Naturalendo Tech Co., Ltd. (KOSDAQ:168330)

South Korea flag South Korea · Delayed Price · Currency is KRW
2,700.00
-30.00 (-1.10%)
At close: Apr 28, 2026
44.15%
Market Cap 85.25B
Revenue (ttm) 22.23B
Net Income (ttm) -3.22B
Shares Out 31.57M
EPS (ttm) -102.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 51,240
Average Volume 43,055
Open 2,730.00
Previous Close 2,730.00
Day's Range 2,665.00 - 2,765.00
52-Week Range 1,862.00 - 6,300.00
Beta 0.26
RSI 59.12
Earnings Date May 22, 2026

About Naturalendo Tech

Naturalendo Tech Co., Ltd. engages in the research, development, manufacture, and sale of natural product new drugs, cosmetics, materials, food additives, and health functional food in South Korea. The company offers EstroG-100, a functional raw material for women's menopause; HabaNova, a diet material; YGF 251, a phyto height growth booster; NET 2401, a multiway sleep-wake cycle regulator; Stauntonia hexaphylla Fruit Extract, an anti-inflammatory superfood; Q.186 complex for improving male menopause; NET 1701, a ultimate men’s prostate and uri... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Employees 81
Stock Exchange KOSDAQ
Ticker Symbol 168330
Full Company Profile

Financial Performance

In 2025, Naturalendo Tech's revenue was 22.23 billion, a decrease of -0.16% compared to the previous year's 22.26 billion. Losses were -3.22 billion, -17.10% less than in 2024.

Financial Statements

News

There is no news available yet.